Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.2099
Nov 17 • 12:26 PM ET Dollar change+0.0001 Percentage change(0.05%)
Nov 16, 7:10 AMXtant Medical withdraws 2026 guidance and announces board-led strategic review
Index
-
Market Cap
29.44M
Enterprise Value
46.45M
Income
-16.01M
Sales
100.56M
Book/sh
0.27
Cash/sh
0.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
151
IPO
Jul 01, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
0.29
P/B
0.79
P/C
3.74
P/FCF
-
EV/EBITDA
-
EV/Sales
0.46
Quick Ratio
0.93
Current Ratio
2.00
Debt/Eq
0.67
LT Debt/Eq
0.21
Option/Short
No / Yes
EPS (ttm)
-0.11
EPS next Y
-0.04
EPS next Q
-0.01
EPS this Y
-400.00%
EPS next Y
61.11%
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
32.20% 20.22%
EPS Y/Y TTM
-1012.80%
Sales Y/Y TTM
-24.44%
EPS Q/Q
-391.95%
Sales Q/Q
-26.97%
Insider Own
12.43%
Insider Trans
0.00%
Inst Own
56.95%
Inst Trans
-0.59%
ROA
-17.63%
ROE
-36.53%
ROIC
-35.62%
Gross Margin
56.40%
Oper. Margin
-15.98%
Profit Margin
-15.92%
SMA20
-24.27%
SMA50
-32.48%
SMA200
-52.27%
Trades
Shs Outstand
140.45M
Shs Float
122.86M
52W High
0.84 -75.01%
52W Low
0.17 23.47%
Volatility
17.95% 11.02%
ATR (14)
0.03
RSI (14)
23.31
Beta
-0.18
Rel Volume
0.29
Avg Volume
1.69M
Volume
237,354
Perf Week
-23.64%
Perf Month
-27.87%
Perf Quarter
-36.41%
Perf Half Y
-54.27%
Perf YTD
-73.23%
Perf Year
-69.27%
Perf 3Y
-81.75%
Perf 5Y
-79.01%
Perf 10Y
-96.50%
Prev Close
0.21
Price
0.21
Change %
0.05%
Consensus
Buy
Avg. Price Target
$0.75
Implied Upside
+257.3%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 05, 2023Initiated
BBTIG Research
Buy$2+852.8%
Nov 15, 2018Reiterated
MMaxim Group
Buy$10 → $6+2,758.5%
Feb 14, 2018Reiterated
MMaxim Group
Buy$18 → $10+4,664.2%
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
PresidentMr. Sean E. Browne
Chief Financial OfficerMr. Scott C. Neils
Chief Operations OfficerMr. Mark A. Schallenberger
Vice President of Human ResourcesMs. Catherine Lundy